Lasa Supergenerics Limited (LASA.BO)
INR 17.88
(2.88%)
INR 17.88
(2.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 205.79 Million INR | -1.86% |
| 2022 | 209.7 Million INR | 130.31% |
| 2021 | 91.05 Million INR | -41.72% |
| 2020 | 156.24 Million INR | -65.98% |
| 2019 | 459.25 Million INR | -46.42% |
| 2018 | 857.17 Million INR | -22.63% |
| 2017 | 1.1 Billion INR | -7.35% |
| 2016 | 1.19 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 873 Thousand INR | -96.35% |
| 2023 Q4 | 205.79 Million INR | 1061.26% |
| 2023 FY | 205.79 Million INR | -1.86% |
| 2023 Q3 | 17.72 Million INR | 1930.01% |
| 2023 Q1 | 23.9 Million INR | -88.6% |
| 2022 Q2 | 185.56 Million INR | 7.94% |
| 2022 FY | 209.7 Million INR | 130.31% |
| 2022 Q1 | 171.91 Million INR | 88.81% |
| 2022 Q3 | 32.43 Million INR | -82.52% |
| 2022 Q4 | 209.7 Million INR | 546.48% |
| 2021 Q2 | -51.38 Million INR | -216.78% |
| 2021 FY | 91.05 Million INR | -41.72% |
| 2021 Q3 | 57.47 Million INR | 211.86% |
| 2021 Q4 | 91.05 Million INR | 58.42% |
| 2021 Q1 | 44 Million INR | -71.84% |
| 2020 Q4 | 156.24 Million INR | 899.32% |
| 2020 Q1 | 60.62 Million INR | -86.8% |
| 2020 Q3 | 15.63 Million INR | -73.47% |
| 2020 Q2 | 58.93 Million INR | -2.79% |
| 2020 FY | 156.24 Million INR | -65.98% |
| 2019 Q2 | 614.56 Million INR | 2188.88% |
| 2019 Q3 | 20.18 Million INR | -96.72% |
| 2019 FY | 459.25 Million INR | -46.42% |
| 2019 Q4 | 459.25 Million INR | 2175.57% |
| 2019 Q1 | 26.85 Million INR | -96.87% |
| 2018 Q4 | 857.17 Million INR | 2700.5% |
| 2018 FY | 857.17 Million INR | -22.63% |
| 2018 Q2 | 877.12 Million INR | 3228.99% |
| 2018 Q1 | 26.34 Million INR | -97.62% |
| 2018 Q3 | 30.6 Million INR | -96.51% |
| 2017 Q1 | 11.62 Million INR | 0.0% |
| 2017 Q2 | 661.06 Million INR | 5587.54% |
| 2017 Q3 | 20.07 Million INR | -96.96% |
| 2017 Q4 | 1.1 Billion INR | 5419.28% |
| 2017 FY | 1.1 Billion INR | -7.35% |
| 2016 FY | 1.19 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 94.677% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 94.428% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 107.24% |
| Granules India Limited | 9.28 Billion INR | 97.784% |
| Indoco Remedies Limited | 6.47 Billion INR | 96.822% |
| Achyut Healthcare Limited | -3.74 Million INR | 5593.833% |
| Ajanta Pharma Limited | -954.9 Million INR | 121.552% |
| Alkem Laboratories Limited | -1.6 Billion INR | 112.787% |
| Alpa Laboratories Limited | 35.36 Million INR | -481.961% |
| Brooks Laboratories Limited | 49.48 Million INR | -315.882% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 104.106% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 93.762% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 117.776% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 98.406% |
| Eris Lifesciences Limited | 13.8 Billion INR | 98.509% |
| FDC Limited | -57.75 Million INR | 456.35% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 104.802% |
| Gufic Biosciences Limited | 3.19 Billion INR | 93.557% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 104.955% |
| Ipca Laboratories Limited | 11.41 Billion INR | 98.197% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 114.806% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 89.353% |
| Laurus Labs Limited | 24.38 Billion INR | 99.156% |
| Lupin Limited | 17.19 Billion INR | 98.803% |
| Mankind Pharma Limited | -9.9 Billion INR | 102.077% |
| Medicamen Biotech Limited | 160.31 Million INR | -28.371% |
| Medico Remedies Limited | 78.67 Million INR | -161.575% |
| Megasoft Limited | 1.28 Billion INR | 83.991% |
| NATCO Pharma Limited | -5.81 Billion INR | 103.538% |
| Piramal Pharma Limited | 42.27 Billion INR | 99.513% |
| RPG Life Sciences Limited | -364.7 Million INR | 156.43% |
| Sigachi Industries Limited | 859.94 Million INR | 76.068% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 100.284% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -41.954% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -345.346% |
| Unichem Laboratories Limited | 931.91 Million INR | 77.917% |
| Wanbury Limited | 1.1 Billion INR | 81.39% |
| Windlas Biotech Limited | -273.04 Million INR | 175.373% |
| ZIM Laboratories Limited | 983.6 Million INR | 79.077% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 94.739% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 121.852% |
| Divi's Laboratories Limited | -39.77 Billion INR | 100.517% |
| Hester Biosciences Limited | 2.29 Billion INR | 91.016% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 108.765% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 182.719% |
| Bal Pharma Limited | 1.26 Billion INR | 83.713% |
| Strides Pharma Science Limited | 23.25 Billion INR | 99.115% |
| Venus Remedies Limited | -267.7 Million INR | 176.877% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 92.121% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 96.658% |
| Shilpa Medicare Limited | 9.06 Billion INR | 97.731% |
| Aarti Drugs Limited | 5.54 Billion INR | 96.291% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 118.687% |
| Suven Life Sciences Limited | -1.63 Billion INR | 112.605% |
| Ind-Swift Limited | 9.5 Billion INR | 97.836% |
| Valiant Laboratories Limited | -295.03 Million INR | 169.755% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 92.705% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 97.948% |
| Themis Medicare Limited | 764.96 Million INR | 73.097% |
| Hikal Limited | 7.96 Billion INR | 97.417% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 99.353% |
| Sequent Scientific Limited | 4.17 Billion INR | 95.075% |
| Novartis India Limited | -5.89 Billion INR | 103.493% |
| Wockhardt Limited | 18.27 Billion INR | 98.874% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 99.24% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 1215.684% |
| Neuland Laboratories Limited | -214.05 Million INR | 196.142% |
| Morepen Laboratories Limited | -231.17 Million INR | 189.023% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -71.443% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 78.91% |